Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Active as of 2024-12-04 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="pqcmc-batch-utilization-terminology"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet pqcmc-batch-utilization-terminology</b></p><a name="pqcmc-batch-utilization-terminology"> </a><a name="hcpqcmc-batch-utilization-terminology"> </a><a name="pqcmc-batch-utilization-terminology-en-US"> </a><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.1.0/CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C133994</td><td>Bioequivalence</td></tr><tr><td>C133992</td><td>Clinical</td></tr><tr><td>C133990</td><td>Commercial</td></tr><tr><td>C133991</td><td>Development</td></tr><tr><td>C133993</td><td>Validation</td></tr><tr><td>C185328</td><td>Stability Study</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="brr"/>
</extension>
<url
value="http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-batch-utilization-terminology"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.36.48.35"/>
</identifier>
<version value="2.0.0-ballot"/>
<name value="PqcmcBatchUtilizationTerminology"/>
<title value="Batch utilization Terminology"/>
<status value="active"/>
<experimental value="false"/>
<date value="2024-12-04T20:50:29+00:00"/>
<publisher value="HL7 International / Biomedical Research and Regulation"/>
<contact>
<name value="HL7 International / Biomedical Research and Regulation"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/rcrim"/>
</telecom>
<telecom>
<system value="email"/>
<value value="brr@lists.HL7.org"/>
</telecom>
</contact>
<description
value="Terminology used to qualify the information pertaining to batch utilization in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="US"/>
<display value="United States of America"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<concept>
<code value="C133994"/>
<display value="Bioequivalence"/>
</concept>
<concept>
<code value="C133992"/>
<display value="Clinical"/>
</concept>
<concept>
<code value="C133990"/>
<display value="Commercial"/>
</concept>
<concept>
<code value="C133991"/>
<display value="Development"/>
</concept>
<concept>
<code value="C133993"/>
<display value="Validation"/>
</concept>
<concept>
<code value="C185328"/>
<display value="Stability Study"/>
</concept>
</include>
</compose>
</ValueSet>